Crispr Therapeutics AG (CRSP)
NASDAQ · Healthcare
Crispr Therapeutics AG Price to Book Ratio 2016–2026
Price to book (P/B) ratio for Crispr Therapeutics AG (CRSP): market cap divided by shareholder equity. As of March 31, 2026 it is 2.38.
From: 03/31/2017To: 03/31/2026
Stock Price
Book Value
Price to Book
Crispr Therapeutics AG Price to Book Ratio — FAQ
Crispr Therapeutics AG (CRSP) price to book ratio over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRSP's price to book ratio history?
The chart and table above show Crispr Therapeutics AG's price to book ratio by year and by quarter, including the growth rate.